Among the prokinetic agents, metoclopramide, a dopamine D2-receptor antagonist, is the only food and drug administration (FDA) approved medication used to treat gastroparesis and, according to guidelines, should not be used for longer than 12 weeks [19] because of the risk of side effects like tardive dyskinesia [20]. The gene discussed is DRD2; the disease is gastroparesis.